EP
BSX icon

Essential Partners’s Boston Scientific BSX Stock Holding History

Essential Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
2,444
+1,428
+141% +$77.5K 0.05% 410
2026
Q1 		$63.8K Buy
1,016
+972
+2,209% +$77.8K 0.02% 538
2025
Q4 		$4.2K Sell
44
-5,204
-99% -$510K ﹤0.01% 1500
2025
Q3 		$512K Sell
5,248
-36
-0.7% -$3.73K 0.17% 171
2025
Q2 		$568K Buy
+5,284
New +$535K 0.23% 134

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Essential Partners's BSX Position: Q2 2026 in Review

Essential Partners increased its Boston Scientific (BSX) stake by 141% in Q2 2026, buying an estimated $77.5K and bringing the position to 2,444 shares worth $104K. The position accounts for 0.05% of the portfolio, ranked #410.

Essential Partners first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $568K in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Essential Partners held 2,444 shares of Boston Scientific worth $104K as of Q2 2026.
  • Essential Partners bought 1,428 Boston Scientific shares in Q2 2026, an estimated $77.5K.
  • Boston Scientific made up 0.05% of Essential Partners's portfolio in Q2 2026, its #410 holding.
  • Essential Partners first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Boston Scientific position peaked at $568K in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.